Skip to content

Sriram Ranga Anbil, MD

NPI 1083173165ActiveIndividual· Internal Medicine, Hematology & Oncology· Media, PA

Internal Medicine, Hematology & Oncology (MD) in Media, Pennsylvania, trained at University of Texas Medical School at San Antonio (class of 2019). Part D covered 23 prescriptions written in 2024, 65% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 16 companies reporting payments in 2025, $715.43 in all, mostly food and beverage.

Overview

NPI1083173165
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 18, 2019
Last updated in NPPESSep 29, 2025
Certified by providerSep 29, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Hematology & Oncology Primary207RH0003XMD490295PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (PA)

Part D prescriptions in 2024

Prescriptions (claims)23 · 29 30-day fills
Patients17
Total drug cost$16,734
Generic share65% of claims

Medicare sources and data years

Education and affiliations

Medical schoolUniversity of Texas Medical School at San Antonio
Graduation year2019
Medicare specialtyHematology/Oncology

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$715.43 · 30 payments from 16 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$715.43 · 30 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records